Articlenpj metabolic health and disease2026

Beta 2 adrenergic receptor agonists as a treatment for metabolic dysfunction-associated steatohepatitis (MASH).

Brennan S Winkler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.